Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

image thumbnail
Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery
Read
BioWorld logo image.png
To read the full story, subscribe or sign in. Appointments and advancements for May 4, 2021
Read
Thepharmaletter logo image.png
New data shows strength in VistaGen’s PH94B for SAD
Read
psychiatric Times logo image.png
A Potential Benzodiazepine Replacement
Read
Medium logo image.png
Shawn Singh of VistaGen Therapeutics: 5 Ways That Businesses Can Help Promote The Mental Wellness Of Their Employees
Read
BioTuesdays logo image.png
VistaGen readies Phase 3 trial of novel, fast-acting neuroactive nasal spray in social anxiety disorder
Read
Crain's logo image.jpg
Local Biotech Firms Poised to Benefit from Rosy Venture Capital Outlook for 2021
Read
STAT logo image
CBC Group sets up AffaMed, EverInsight merger, eyes IPO
Read
psychiatric Times logo image
Complementing Your Psychotherapy
Read